<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9690455" created="20/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9690455</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Ex vivo <term id="T1" sem="Other">activation</term> of <term id="T2" lex="tumor-draining_lymph_node_T_cell" sem="Cell_natural">tumor-draining lymph node <term id="T3" lex="T_cell" sem="Cell_natural">T cells</term></term> reverses defects in <term id="T4" lex="signal_transduction_molecule" sem="Protein_family_or_group">signal transduction molecules</term>.</sentence>
<event id="E1">
<type class="Physiological_process"/>
<theme idref="T3"/>
<clue>Ex vivo <clueType>activation</clueType> <linkTheme>of</linkTheme> <clueLoc>tumor-draining lymph node</clueLoc> T cells reverses defects in signal transduction molecules.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E57"/>
<cause idref="E1"/>
<clue>Ex vivo activation of tumor-draining lymph node T cells <clueType>reverses</clueType> defects in signal transduction molecules.</clue>
</event>
<event KT="Other" id="E57">
<type class="Negative_regulation"/>
<theme idref="T4"/>
<clue>Ex vivo activation of tumor-draining lymph node T cells reverses <clueType>defects</clueType> <linkTheme>in</linkTheme> signal transduction molecules.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The adoptive transfer of <term id="T5" lex="tumor-draining_lymph_node" sem="Body_region">tumor-draining lymph node</term> (<term id="T6" lex="LN" sem="Body_region">LN</term>) <term id="T7" lex="T_cell" sem="Cell_natural">T cells</term> activated ex vivo with <term id="T9" lex="anti-CD3" sem="Protein_molecule">anti-CD3</term> and <term id="T10" lex="interleukin_2" sem="Protein_molecule">interleukin 2</term> (<term id="T11" lex="IL-2" sem="Protein_molecule">IL-2</term>) mediates the regression of the <term id="T12" lex="poorly_immunogenic_murine_melanoma_D5" sem="Tissue_natural">poorly immunogenic murine melanoma <term id="T13" lex="D5" sem="Tissue_natural">D5</term></term>.</sentence>
<event KT="Other" id="E3">
<type class="Physiological_process"/>
<theme idref="T7"/>
<cause idref="T9"/>
<clue>The adoptive transfer of <clueLoc>tumor-draining lymph node</clueLoc> (LN) T cells <clueType>activated</clueType> ex vivo <linkCause>with</linkCause> anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.</clue>
</event>
<event KT="Other" id="E4">
<type class="Physiological_process"/>
<theme idref="T7"/>
<cause idref="T11"/>
<clue>The adoptive transfer of <clueLoc>tumor-draining lymph node</clueLoc> (LN) T cells <clueType>activated</clueType> ex vivo <linkCause>with</linkCause> anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.</clue>
</event>
<event KT="Method" id="E5">
<type class="Artificial_process"/>
<theme idref="E3"/>
<clue>The <clueType>adoptive transfer</clueType> <linkTheme>of</linkTheme> tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.</clue>
</event>
<event KT="Method" id="E6">
<type class="Artificial_process"/>
<theme idref="E4"/>
<clue>The <clueType>adoptive transfer</clueType> <linkTheme>of</linkTheme> tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E5"/>
<clue>The adoptive transfer of tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) <clueType>mediates</clueType> the regression of the poorly immunogenic murine melanoma D5.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E6"/>
<clue>The adoptive transfer of tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) <clueType>mediates</clueType> the regression of the poorly immunogenic murine melanoma D5.</clue>
</event>
<event KT="Other" id="E9">
<type class="Negative_regulation"/>
<theme idref="T13"/>
<clue>The adoptive transfer of tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) mediates the <clueType>regression</clueType> <linkTheme>of</linkTheme> the poorly immunogenic murine melanoma D5.</clue>
</event>
<sentence id="S3">The efficacy of the activated <term id="T15" lex="LN_cell" sem="Cell_natural">LN cells</term> is augmented when the sensitizing tumor is a <term id="T16" lex="genetically_modified_variant" sem="Cell_cultured">genetically modified variant</term> (designated <term id="T17" lex="D5G6" sem="Cell_cultured">D5G6</term>) that secretes <term id="T18" lex="granulocyte/macrophage-colony-stimulating_factor" sem="Protein_molecule">granulocyte/macrophage-colony-stimulating factor</term>.</sentence>
<event KT="Other" id="E10">
<type class="Physiological_process"/>
<theme idref="T15"/>
<clue>The efficacy of the <clueType>activated</clueType> LN cells is augmented when the sensitizing tumor is a genetically modified variant (designated D5G6) that secretes granulocyte/macrophage-colony-stimulating factor.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T17"/>
<clue>The <clueType>efficacy</clueType> <linkTheme>of</linkTheme> the activated LN cells is <clueType>augmented</clueType> <linkCause>when</linkCause> the sensitizing tumor is a genetically modified variant (designated D5G6) that secretes granulocyte/macrophage-colony-stimulating factor.</clue>
</event>
<event KT="Other" id="E13">
<type class="Localization"/>
<theme idref="T18"/>
<clue>The efficacy of the activated LN cells is augmented when the sensitizing tumor is a <clueLoc>genetically modified variant (designated D5G6)</clueLoc> that <clueType>secretes</clueType> granulocyte/macrophage-colony-stimulating factor.</clue>
</event>
<sentence id="S4">In contrast to <term id="A2" sem="Protein_molecule">anti-CD3</term>/<term id="T20" lex="IL-2" sem="Protein_molecule">IL-2</term>-activated <term id="T22" lex="LN_cell" sem="Cell_natural">LN cells</term>, adoptive transfer of freshly isolated <term id="T23" lex="tumor-draining_LN_T_cell" sem="Cell_natural">tumor-draining LN T cells</term> has no <term id="T24" lex="therapeutic_activity" sem="Other">therapeutic activity</term>.</sentence>
<event KT="Other" id="E15">
<type class="Physiological_process"/>
<theme idref="T22"/>
<cause idref="A2"/>
<cause idref="T20"/>
<clue>In contrast to anti-CD3/IL-2-<clueType>activated</clueType> LN cells, adoptive transfer of freshly isolated tumor-draining LN T cells has no therapeutic activity.</clue>
</event>
<event KT="Fact" id="E16">
<type class="Regulation"/>
<theme idref="T24"/>
<cause idref="E15"/>
<clue>In contrast to anti-CD3/IL-2-activated LN cells, adoptive transfer of freshly isolated tumor-draining LN T cells has no <clueType>therapeutic activity</clueType>.</clue>
<comment>NO THEME; CAUTION: SEE</comment></event>
<event KT="Method" id="E17">
<type class="Artificial_process"/>
<theme idref="T23"/>
<clue>In contrast to anti-CD3/IL-2-activated LN cells, <clueType>adoptive transfer</clueType> <linkTheme>of</linkTheme> freshly isolated tumor-draining LN T cells has no therapeutic activity.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E18">
<type class="Regulation"/>
<cause idref="E17"/>
<clue>In contrast to anti-CD3/IL-2-activated LN cells, adoptive transfer of freshly isolated tumor-draining LN T cells has <cluePolarity>no</cluePolarity> <clueType>therapeutic activity</clueType>.</clue>
<comment>NO THEME</comment></event>
<sentence id="S5">To determine whether the acquisition of <term id="T25" lex="antitumor_function" sem="Other">antitumor function</term> during ex vivo activation is associated with modifications in <term id="T26" lex="signal_transduction_capacity" sem="Other">signal transduction capacity</term>, the <term id="A1" sem="Protein_family_or_group">protein <term id="T27" lex="tyrosine_kinase" sem="Protein_family_or_group"><term id="T28" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term> kinases</term></term> <term id="T29" lex="p56lck" sem="Protein_molecule">p56lck</term> and <term id="T30" lex="p59fyn" sem="Protein_molecule">p59fyn</term> and proteins of the <term id="T31" lex="NF-kappaB_family" sem="Protein_family_or_group">NF-kappaB family</term> were analyzed in <term id="T32" lex="tumor-draining_LN_T_cell" sem="Cell_natural">tumor-draining LN T cells</term>.</sentence>
<event KT="Other" id="E19" uncertainty="doubtful">
<type class="Physiological_process"/>
<theme idref="T32"/>
<cause idref="E20"/>
<clue>To determine whether the <clueType>acquisition</clueType> <linkTheme>of</linkTheme> antitumor function <linkCause>during</linkCause> ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.</clue>
</event>
<event KT="Other" id="E20">
<type class="Physiological_process"/>
<theme idref="T32"/>
<clue>To determine whether the acquisition of antitumor function during ex vivo <clueType>activation</clueType> is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.</clue>
</event>
<event KT="Investigation" id="E21" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E19"/>
<theme idref="E22"/>
<clue><clueKT>To determine</clueKT> whether the acquisition of antitumor function during ex vivo activation is <clueType>associated</clueType> <linkTheme>with</linkTheme> modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.</clue>
</event>
<event KT="Other" id="E22">
<type class="Regulation"/>
<theme idref="T26"/>
<clue>To determine whether the acquisition of antitumor function during ex vivo activation is associated with <clueType>modifications</clueType> <linkTheme>in</linkTheme> signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.</clue>
</event>
<event KT="Investigation" id="E23" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A1" idref1="T29"/>
<clue>To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were <clueType><clueKT>analyzed</clueKT></clueType> <clueLoc>in tumor-draining LN T cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E24" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A1" idref1="T30"/>
<clue>To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were <clueType><clueKT>analyzed</clueKT></clueType> <clueLoc>in tumor-draining LN T cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E25" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T31"/>
<clue>To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were <clueType><clueKT>analyzed</clueKT></clueType> <clueLoc>in tumor-draining LN T cells</clueLoc>.</clue>
</event>
<sentence id="S6">The levels of <term id="T33" lex="p56lck" sem="Protein_molecule">p56lck</term> and <term id="T34" lex="p59fyn" sem="Protein_molecule">p59fyn</term> were lower in <term id="A4" sem="Other">tumor-draining</term> than in <term id="T35" lex="normal_LN_T_cell" sem="Cell_natural">normal <term id="A5" sem="Cell_natural">LN T cells</term></term> and production of <term id="T36" lex="tyrosine-phosphorylated_substrate" sem="Protein_family_or_group"><term id="T37" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term>-phosphorylated <term id="A3" sem="Protein_family_or_group">substrates</term></term> was markedly depressed following <term id="T38" lex="anti-CD3_stimulation" sem="Other"><term id="T39" lex="anti-CD3" sem="Protein_molecule">anti-CD3</term> stimulation</term>.</sentence>
<event id="E26">
<type class="Gene_expression"/>
<theme idref="T33"/>
<clue>The <clueType>levels</clueType> of p56lck and p59fyn were lower <clueLoc>in tumor-draining</clueLoc> than in normal <clueLoc>LN T cells</clueLoc> and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 stimulation.</clue>
</event>
<event id="E14">
<type class="Gene_expression"/>
<theme idref="T33"/>
<clue>The <clueType>levels</clueType> of p56lck and p59fyn were lower in tumor-draining than <clueLoc>in normal LN T cells</clueLoc> and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 stimulation.</clue>
</event>
<event id="E27">
<type class="Gene_expression"/>
<theme idref="T34"/>
<clue>The <clueType>levels</clueType> of p56lck and p59fyn were lower <clueLoc>in tumor-draining</clueLoc> than in normal <clueLoc>LN T cells</clueLoc> and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 stimulation.</clue>
</event>
<event id="E28">
<type class="Gene_expression"/>
<theme idref="T34"/>
<clue>The <clueType>levels</clueType> of p56lck and p59fyn were lower in tumor-draining than <clueLoc>in normal LN T cells</clueLoc> and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 stimulation.</clue>
</event>
<event KT="Other" id="E29">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="A3"/>
<site idref="T37"/>
<clue>The levels of p56lck and p59fyn were lower in tumor-draining than in normal LN T cells and <clueType>production of</clueType> tyrosine-<clueType>phosphorylated</clueType> substrates was markedly depressed following anti-CD3 stimulation.</clue>
</event>
<event Manner="High" id="E30">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="E31"/>
<clue>The levels of p56lck and p59fyn were lower in tumor-draining than in normal LN T cells and production of tyrosine-phosphorylated substrates was <clueManner>markedly</clueManner> <clueType>depressed</clueType> <linkCause>following</linkCause> anti-CD3 stimulation.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="A4" idref1="A5"/>
<cause idref="T39"/>
<clue>The levels of p56lck and p59fyn were lower in tumor-draining than in normal LN T cells and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 <clueType>stimulation</clueType>.</clue>
</event>
<sentence id="S7">After 5-day <term id="T40" lex="anti-CD3" sem="Protein_molecule">anti-CD3</term><term id="T41" lex="IL-2" sem="Protein_molecule">/IL-2</term> activation, levels of <term id="T42" lex="p56lck" sem="Protein_molecule">p56lck</term> and <term id="T43" lex="p59fyn" sem="Protein_molecule">p59fyn</term> and <term id="T44" lex="protein_tyrosine_kinase_activity" sem="Other"><term id="A10" sem="Protein_family_or_group"><term id="T45" sem="Amino_acid_monomer">protein tyrosine</term> kinase</term> activity</term> increased.</sentence>
<event id="E32">
<type class="Physiological_process"/>
<theme idref="A4" idref1="A5"/>
<cause idref="T40"/>
<cause idref="T41"/>
<clue>After <clueTime>5-day</clueTime> anti-CD3/IL-2 <clueType>activation</clueType>, levels of p56lck and p59fyn and protein tyrosine kinase activity increased.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="E32"/>
<clue><linkCause>After</linkCause> 5-day anti-CD3/IL-2 activation, levels of p56lck and p59fyn and protein tyrosine kinase activity <clueType>increased</clueType>.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="E32"/>
<clue><linkCause>After</linkCause> 5-day anti-CD3/IL-2 activation, levels of p56lck and p59fyn and protein tyrosine kinase activity <clueType>increased</clueType>.</clue>
</event>
<event id="E35">
<type class="Positive_regulation"/>
<theme idref="A10"/>
<cause idref="E32"/>
<clue><linkCause>After</linkCause> 5-day anti-CD3/IL-2 activation, levels of p56lck and p59fyn and protein tyrosine kinase <clueType>activity increased</clueType>.</clue>
</event>
<event id="E36">
<type class="Gene_expression"/>
<theme idref="T42"/>
<clue>After 5-day anti-CD3/IL-2 activation, <clueType>levels</clueType> <linkTheme>of</linkTheme> p56lck and p59fyn and protein tyrosine kinase activity increased.</clue>
</event>
<event id="E37">
<type class="Gene_expression"/>
<theme idref="T43"/>
<clue>After 5-day anti-CD3/IL-2 activation, <clueType>levels</clueType> <linkTheme>of</linkTheme> p56lck and p59fyn and protein tyrosine kinase activity increased.</clue>
</event>
<sentence id="S8">Interestingly, the levels of <term id="T46" lex="p56lck" sem="Protein_molecule">p56lck</term>, <term id="T47" lex="p59fyn" sem="Protein_molecule">p59fyn</term>, and <term id="T48" lex="tyrosine_kinase_activity" sem="Other"><term id="A9" sem="Protein_family_or_group"><term id="T49" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term> kinase</term> activity</term> were higher in activated <term id="A8" sem="Cell_natural">T cells</term> derived from <term id="T51" lex="LN" sem="Body_region">LN</term> that drained <term id="T52" lex="D5G6" sem="Tissue_natural">D5G6</term> than they were in those from <term id="T53" lex="D5_tumor" sem="Tissue_natural">D5 tumors</term>.</sentence>
<event id="E38">
<type class="Physiological_process"/>
<theme idref="A8"/>
<clue>Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in <clueType>activated</clueType> T cells derived <clueLoc>from LN that drained D5G6</clueLoc> than they were in those from D5 tumors.</clue>
</event>
<event id="E39">
<type/>
<theme idref="T52"/>
<cause idref="T51"/>
<clue>Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that <clueType>drained</clueType> D5G6 than they were in those from D5 tumors.</clue>
<comment>SOO</comment></event>
<event id="E40">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>Interestingly, the <clueType>levels</clueType> <linkTheme>of</linkTheme> p56lck, p59fyn, and tyrosine kinase activity were higher <clueLoc>in activated T cells derived from LN that drained D5G6</clueLoc> than they were in those from D5 tumors.</clue>
</event>
<event id="E41">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue>Interestingly, the <clueType>levels</clueType> <linkTheme>of</linkTheme> p56lck, p59fyn, and tyrosine kinase activity were higher <clueLoc>in activated T cells derived from LN that drained D5G6</clueLoc> than they were in those from D5 tumors.</clue>
</event>
<event id="E59">
<type class="Positive_regulation"/>
<theme idref="A9"/>
<clue>Interestingly, the <clueType>levels</clueType> <linkTheme>of</linkTheme> p56lck, p59fyn, and tyrosine kinase <clueType>activity</clueType> were higher <clueLoc>in activated T cells derived from LN that drained D5G6</clueLoc> than they were in those from D5 tumors.</clue>
</event>
<event id="E42">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than <corefTheme>they</corefTheme> <clueType>were</clueType> <clueLoc>in those from D5 tumors</clueLoc>.</clue>
<comment>CAUTION: were</comment></event>
<event id="E43">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue>Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than <corefTheme>they</corefTheme> <clueType>were</clueType> <clueLoc>in those from D5 tumors</clueLoc>.</clue>
<comment>CAUTION: were</comment></event>
<event id="E63">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<clue>Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than <corefTheme>they</corefTheme> <clueType>were</clueType> <clueLoc>in those from D5 tumors</clueLoc>.</clue>
<comment>CAUTION: were</comment></event>
<event id="E44">
<type/>
<theme idref="A8"/>
<cause idref="T53"/>
<clue>Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than they were in <corefTheme>those</corefTheme> <linkCause>from</linkCause> D5 tumors.</clue>
<comment>SOO: =drained from</comment></event>
<sentence id="S9">In contrast, the <term id="T54" lex="cytoplasmic_level" sem="Other">cytoplasmic levels</term> of <term id="T55" lex="c-Rel" sem="Protein_molecule">c-Rel</term> and <term id="T56" lex="Rel_A" sem="Protein_molecule">Rel A</term> were normal in freshly isolated <term id="T57" lex="tumor-draining_LN" sem="Body_region">tumor-draining LN</term>, as was <term id="T58" lex="nuclear_kappaB_DNA-binding_activity" sem="Other">nuclear <term id="T59" lex="kappaB" sem="Protein_molecule">kappaB</term> <term id="A11" sem="DNA_domain_or_region">DNA</term>-binding activity</term> induced by <term id="T60" lex="anti-CD3_mAb" sem="Protein_molecule"><term id="T61" lex="anti-CD3" sem="Protein_molecule">anti-CD3</term> mAb</term> or <term id="T62" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term>.</sentence>
<event CL="L2" KT="Analysis" id="E45">
<type class="Gene_expression"/>
<theme idref="T55"/>
<clue>In contrast, the <clueLoc>cytoplasmic</clueLoc> <clueType>levels</clueType> <linkTheme>of</linkTheme> c-Rel and Rel A were <clueKT><clueCL>normal</clueCL></clueKT> <clueLoc>in freshly isolated tumor-draining LN</clueLoc>, as was nuclear kappaB DNA-binding activity induced by anti-CD3 mAb or phorbol myristate acetate.</clue>
</event>
<event CL="L2" KT="Analysis" id="E46">
<type class="Gene_expression"/>
<theme idref="T56"/>
<clue>In contrast, the <clueLoc>cytoplasmic</clueLoc> <clueType>levels</clueType> <linkTheme>of</linkTheme> c-Rel and Rel A were <clueKT><clueCL>normal</clueCL></clueKT> <clueLoc>in freshly isolated tumor-draining LN</clueLoc>, as was nuclear kappaB DNA-binding activity induced by anti-CD3 mAb or phorbol myristate acetate.</clue>
</event>
<event id="E47">
<type class="Binding"/>
<theme idref="T59"/>
<theme idref="A11"/>
<clue>In contrast, the cytoplasmic levels of c-Rel and Rel A were normal in freshly isolated tumor-draining LN, as was nuclear kappaB DNA-<clueType>binding</clueType> activity induced by anti-CD3 mAb or phorbol myristate acetate.</clue>
</event>
<event id="E58">
<type class="Positive_regulation"/>
<theme idref="E47"/>
<cause idref="T61"/>
<clue>In contrast, the cytoplasmic levels of c-Rel and Rel A were normal in freshly isolated tumor-draining LN, as was nuclear kappaB DNA-binding activity <clueType>induced</clueType> <linkCause>by</linkCause> anti-CD3 mAb or phorbol myristate acetate.</clue>
</event>
<event id="E48">
<type class="Positive_regulation"/>
<theme idref="E47"/>
<cause idref="T62"/>
<clue>In contrast, the cytoplasmic levels of c-Rel and Rel A were normal in freshly isolated tumor-draining LN, as was nuclear kappaB DNA-binding activity <clueType>induced</clueType> <linkCause>by</linkCause> anti-CD3 mAb or phorbol myristate acetate.</clue>
</event>
<sentence id="S10">Stimulation of <term id="T63" lex="activated_LN_cell" sem="Cell_natural">activated <term id="T64" lex="LN_cell" sem="Cell_natural">LN cells</term></term> with <term id="T65" lex="D5_tumor_cell" sem="Cell_natural">D5 tumor cells</term> induced the nuclear translocation of <term id="T66" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>.</sentence>
<event id="E49">
<type class="Physiological_process"/>
<theme idref="E50"/>
<cause idref="T65"/>
<clue><clueType>Stimulation</clueType> <linkTheme>of</linkTheme> activated LN cells <linkCause>with</linkCause> D5 tumor cells induced the nuclear translocation of NF-kappaB.</clue>
</event>
<event id="E50">
<type class="Physiological_process"/>
<theme idref="T64"/>
<clue>Stimulation of <clueType>activated</clueType> LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB.</clue>
</event>
<event id="E51">
<type class="Positive_regulation"/>
<theme idref="E52"/>
<cause idref="E49"/>
<clue>Stimulation of activated LN cells with D5 tumor cells <clueType>induced</clueType> the nuclear translocation of NF-kappaB.</clue>
</event>
<event id="E52">
<type class="Localization"/>
<theme idref="T66"/>
<clue>Stimulation of activated LN cells with D5 tumor cells induced the <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> NF-kappaB.</clue>
</event>
<sentence id="S11">These findings indicate that the recovery of <term id="A6" sem="Protein_family_or_group">proteins</term> mediating <term id="A7" sem="Other">signal transduction</term> through the <term id="T67" lex="T_cell_receptor/CD3_complex" sem="Protein_complex">T cell receptor/CD3 complex</term> in <term id="T68" lex="LN_T_cell" sem="Cell_natural">LN T cells</term> activated ex vivo was associated with the acquisition of <term id="T69" lex="antitumor_function" sem="Other">antitumor function</term>.</sentence>
<event KT="Other" id="E53">
<type class="Positive_regulation"/>
<theme idref="E54"/>
<clue>These findings indicate that the <clueType>recovery</clueType> <linkTheme>of</linkTheme> proteins mediating signal transduction through the T cell receptor/CD3 complex <clueLoc>in LN T cells activated ex vivo</clueLoc> was associated with the acquisition of antitumor function.</clue>
</event>
<event KT="Other" id="E12">
<type class="Cell_communication"/>
<theme idref="T67"/>
<clue>These findings indicate that the recovery of proteins mediating <clueType>signal transduction</clueType> <linkTheme>through</linkTheme> the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.</clue>
</event>
<event KT="Other" id="E54">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="A6"/>
<clue>These findings indicate that the recovery of proteins <clueType>mediating</clueType> signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.</clue>
</event>
<event KT="Other" id="E55">
<type class="Physiological_process"/>
<theme idref="T68"/>
<clue>These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells <clueType>activated</clueType> ex vivo was associated with the acquisition of antitumor function.</clue>
</event>
<event CL="L2" KT="Analysis" id="E64">
<type class="Correlation"/>
<theme idref="E53"/>
<theme idref="E56"/>
<clue>These findings <clueCL>indicate</clueCL> that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> the acquisition of antitumor function.</clue>
</event>
<event KT="Other" id="E56">
<type class="Positive_regulation"/>
<theme idref="T69"/>
<clue>These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the <clueType>acquisition</clueType> <linkTheme>of</linkTheme> antitumor function.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
